The 2003 Canadian recommendations for dyslipidemia management: Revisions are needed

CMAJ. Canadian Medical Association Journal

Volumn 172, Issue 8, 2005, Pages 1027-1037

  Manuel, Douglas G ^a,b,f,g   Tanuseputro, Peter ^a   Mustard, Cameron A ^b,c   Schultz, Susan E ^a   Anderson, Geoffrey M ^a,b   Ardal, Sten ^d   Alter, David A ^a,e   Laupacis, Andreas ^a,b,f   Genest, Jacques ^h   McPherson, Ruth ⁱ   Frohlich, Jiri ⁱ   Fodor, George ^j  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR WORK AND HEALTH   (Canada)

^d Ctrl E Hlth Info Partnership   (Canada)

^e Schulich Heart Centre   (Canada)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^g Ontario Min Hlth Long Term Care   (Canada)

^h ROYAL VICTORIA HOSPITAL   (Canada)

ⁱ UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

STATINE DERIVATIVE;

CANADA; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG COST; DYSLIPIDEMIA; HEALTH CARE COST; HEALTH SURVEY; HUMAN; NOTE; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST;

EID: 20244362794     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.1040202     Document Type: Note

References (0)